SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPollen Street Regulatory News (POLN)

Share Price Information for Pollen Street (POLN)

Share Price is delayed by 15 minutes
Get Live Data
867.00    15.00 (1.76%)
Bid:
867.00
Ask:
873.00
Spread: 6.00 (0.692%)
Market Cap: £515.62m
POLN Live PriceLast checked at - London Stock Exchange

Intraday Pollen Street Share Chart

Q4 2023 Trading Update

28 Feb 2024 07:00

RNS Number : 6727E
Pollen Street Group Ltd
28 February 2024
 

FOR IMMEDIATE RELEASE

28 February 2024

Pollen Street Group Limited Q4 Trading Update

Pollen Street Group Limited ("Pollen Street" or the "Group") today issues its trading update for the quarter ended 31 December 2023.

Highlights

· Fundraising is progressing well across Private Equity and Private Credit.

Fundraising for the Private Equity strategy has been strong having secured commitments in excess of £1.3 billion since 30 June 2023 across the Continuation Vehicle and Fund V

We are approaching first close for Private Credit fund IV ahead of plan and have recently closed a £225 million separately managed account ("SMA") under the Credit Strategy to support strong momentum in AuM throughout 2024

· Deployment is also strong with Fee-Paying AuM closing the period at £3.4 billion, up 36 per cent from £2.5 billion as at 31 December 2022

· The Investment Company returns remain robust with stable credit performance and rising yields

Asset Manager

The Private Equity and Private Credit strategies are performing well. Private Equity fundraising is progressing well with commitments of approximately half the target secured, and we remain confident in reaching the full ?1 billion. In Private Credit, we have recently closed a £225 million SMA and expect to hold the first close of Private Credit fund IV in the first half of 2024, giving clear line of sight to Credit AuM growth across 2024. The AuM on an investor commitment basis as at 31 December 2023 was £4.2 billion, up 24 per cent from £3.4 billion as at 31 December 2022. We expect this momentum to continue. We are also seeing attractive deployment opportunities across both strategies, bringing Fee-Paying AuM to £3.4 billion as at 31 December 2023, which results in Average Fee-Paying AuM of £2.9 billion for the year.

Investment Company

The Return on Net Investment Assets was consistent for Q4 resulting in 8.8 per cent return for 2023. The return was driven by a strong risk-adjusted yield of 11.3 per cent in 2023, up from 9.4 per cent in 2022, an increase of 2 per cent, reflecting the re-pricing of facilities into the higher interest rate environment.

We have committed over £120 million of the Investment Company's balance sheet into Pollen Street managed funds to support the fundraising efforts of the Asset Manager. We have also created capacity for a commitment into the first close of Private Credit fund IV. This has resulted in Net Debt to Tangible Equity reducing to 54 per cent as at 31 December 2023 compared to 69 per cent as at 31 December 2022.

Performance remains strong, benefitting from the senior secured strategy, even amidst a changing macroeconomic environment. The portfolio remains well positioned with a good pipeline of opportunities.

About Pollen Street Group Limited

Pollen Street is an alternative asset manager dedicated to investing with the financial and business services sectors across both Private Equity and Private Credit strategies. The business was founded in 2013 and has consistently delivered top tier returns alongside growing AuM.

Pollen Street benefits from a complementary set of asset management activities focused on managing third-party AuM (the "Asset Manager") and on-balance sheet investments (the "Investment Company").

The Asset Manager raises capital from top tier investors and deploys it into its Private Equity and Private Credit strategies. The strong recurring revenues from this business enable delivery of scalable growth.

The Investment Company invests in the strategies of the Group delivering attractive risk adjusted returns. Today the portfolio is a well-diversified pool of primarily senior asset-backed credit assets generating strong returns at conservative loan to value ratios ("LTVs"). The portfolio consists of both direct investments and investments in funds managed by Pollen Street.

POLN is listed on the London Stock Exchange (ticker symbol: POLN). Further details are available at www.pollenstreetgroup.com.

For further information about this announcement please contact:

 

Barclays Bank plc - Joint Broker

Neal West / Stuart Muress

+44 (0)20 7623 2323

 

Investec Bank plc - Joint Broker

Bruce Garrow / Ben Griffiths

+44 (0)20 7597 4000

 

FGS Global

Chris Sibbald

Chris.Sibbald@fgsglobal.com

 

Link Company Matters Limited - Corporate Secretary

polncosec@linkgroup.co.uk

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBONRSSUUUAR
Date   Source Headline
1st Jun 20263:01 pmRNSTotal Voting Rights
27th May 20264:46 pmRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
11th May 20265:39 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSQ1 2026 Trading Update
6th May 20264:40 pmRNSDirector/PDMR Shareholding
1st May 20269:49 amRNSTotal Voting Rights
1st May 20268:12 amRNSResult of AGM
28th Apr 20264:31 pmRNSDirector/PDMR Shareholding
16th Apr 20265:31 pmRNSInvestor Presentation via Investor Meet Company
14th Apr 20267:00 amRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
27th Mar 202610:36 amRNSDirector/PDMR Shareholding
26th Mar 20264:37 pmRNSDirector/PDMR Shareholding
26th Mar 20267:30 amRNSDividend Declaration
26th Mar 20267:00 amRNSFull Year 2025 Trading Update
2nd Mar 202611:26 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20261:57 pmRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20264:32 pmRNSDirector/PDMR Shareholding
2nd Feb 20263:12 pmRNSTotal Voting Rights
30th Jan 202610:59 amRNSDirectorate changes
28th Jan 202611:37 amRNSDirector/PDMR Shareholding
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSDirectorate change
23rd Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 20254:27 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20259:50 amRNSUpdate Statement on 2025 AGM Voting Results
1st Dec 202511:15 amRNSTotal Voting Rights
28th Nov 20256:23 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSQ3 2025 Trading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSAnnouncement of New Share Buyback Programme
16th Oct 20256:16 pmRNSHolding(s) in Company
3rd Oct 202511:32 amRNSDirector/PDMR Shareholding
1st Oct 20255:12 pmRNSDirector/PDMR Shareholding
30th Sep 20254:07 pmRNSInvestor Presentation via Investor Meet Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.